Significant Revenue and EBITDA Growth
Q4 2024 revenue increased to $389 million compared to $277 million in Q4 2023, representing a 41% improvement. Adjusted EBITDA grew to $118 million, a 107% year-over-year improvement.
Operational Efficiency and Submission Volume Increase
Submission volume increased in Q4 2024 by 67% year-over-year, with the captive Medicare team seeing an 82% increase in submissions and external agents showing a 25% increase.
Reduced Customer Acquisition Costs
Direct operating cost per submission decreased by 27% year-over-year in Q4 to $501.
e-TeleQuote Integration Success
e-TeleQuote business delivered 54,000 submissions during AEP, a 170% improvement year-over-year.
PlanFit Technology Platform Expansion
PlanFit CheckUp grew 72% in Q4 2024 compared to the same period in 2023, demonstrating strong consumer engagement.